Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists. Invest New Drugs. 2005 Oct; 23(5):417-28.
View in:
PubMed
subject areas
Alanine Transaminase
Alanine Transaminase
Animals
Animals
Antineoplastic Agents
Antineoplastic Agents
Apoptosis
Apoptosis
Cell Differentiation
Cell Differentiation
Cell Line, Tumor
Cell Line, Tumor
Cell Proliferation
Cell Proliferation
Chromans
Chromans
Female
Female
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Humans
Humans
Mice
Mice
Mice, Inbred Strains
Mice, Inbred Strains
Ovarian Neoplasms
Ovarian Neoplasms
Phenylurea Compounds
Phenylurea Compounds
Receptors, Retinoic Acid
Receptors, Retinoic Acid
Retinoid X Receptors
Retinoid X Receptors
RNA
RNA
Skin Irritancy Tests
Skin Irritancy Tests
Thiones
Thiones
Thiourea
Thiourea
Uterine Cervical Neoplasms
Uterine Cervical Neoplasms
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Bethany Noelle Hannafon
Doris M Benbrook
Kenneth Darrell Berlin